SCHEMBL781876

SCHEMBL781876

O=COc1ccc2cccc3c4cccc5cccc(c1c23)c54

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.47
CYP1A2 P05177 5/20 0.47
ALDH1A1 P00352 4/20 0.47
HSD17B10 Q99714 4/20 0.47
THRB P10828 1/20 0.47
ERBB2 P04626 1/20 0.39
FYN P06241 1/20 0.39
MAOA P21397 1/20 0.39
ACHE P22303 1/20 0.39
AHR P35869 1/20 0.39
L3MBTL1 Q9Y468 3/20 0.36
MAPT P10636 3/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
GAA P10253 1/20 0.36
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
CYP3A4 P08684 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28964515 0.84 CYP1A2 (0.39) HPGDCYP1A2ALDH1A1HSD17B10THRB
SCHEMBL473050 0.81 ALDH1A1 (0.44) HPGDCYP1A2ALDH1A1HSD17B10THRB
SCHEMBL28233231 0.80 ALDH1A1 (0.42) HPGDCYP1A2ALDH1A1HSD17B10THRB
SCHEMBL28250584 0.80 ALDH1A1 (0.43) HPGDCYP1A2ALDH1A1HSD17B10THRB
SCHEMBL4564700 0.79 ALDH1A1 (0.56) HPGDCYP1A2ALDH1A1HSD17B10THRB
SCHEMBL28232293 0.79 ALDH1A1 (0.42) HPGDCYP1A2ALDH1A1HSD17B10THRB
SCHEMBL24717764 0.78 ALDH1A1 (0.39) HPGDCYP1A2ALDH1A1HSD17B10THRB
SCHEMBL4406270 0.76 HPGD (0.52) HPGDCYP1A2ALDH1A1HSD17B10THRB
SCHEMBL2585748 0.75 ALDH1A1 (0.47) HPGDCYP1A2ALDH1A1HSD17B10THRB
SCHEMBL4080090 0.75 ALDH1A1 (0.47) HPGDCYP1A2ALDH1A1HSD17B10THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110373073-A A kind of preparation process of ultrasound electric machine composite friction material 江苏紫金东方超声电机有限公司 2019-10-25 CN claimed
CN-109671951-A A kind of lithium ion battery conductive agent preparation process based on modified graphene 安徽兆拓新能源科技有限公司 2019-04-23 CN claimed
CN-103130211-A Preparation method of graphene UNIV XIDIAN 2013-06-05 CN claimed
CN-101263608-B Fluorescent solar conversion cell based on fluorescent trinaphthylene dyes BASF SE 2010-07-21 CN claimed
CN-101263608-A Fluorescent solar conversion cell based on fluorescent trinaphthylene dyes BASF SE (DE) 2008-09-10 CN claimed
EP-1468042-B1 MATERIAL FOR THE PRODUCTION OF FUNCTIONAL ELEMENTS COMPRISING AT LEAST ONE FOAMABLE AREA AND USE OF SAID FUNCTIONAL ELEMENTS FOR POSITIONING AND MOUNTING OBJECTS JENOPTIK AUTOMATISIERUNGSTECH (DE) 2007-04-18 EP claimed
CN-1243511-A Preparation of -3,4-dicarboxylic anhydrides CIBA SC HOLDING AG (CH) 2000-02-02 CN claimed
CN-120054638-A Visible light catalytic composite material, preparation method and application thereof 哈尔滨工业大学(深圳)(哈尔滨工业大学深圳科技创新研究院) 2025-05-30 CN disclosed
US-12261143-B2 Method of manufacturing substrate layered body and layered body MITSUI CHEMICALS, INC. (JP) 2025-03-25 US disclosed
CN-118185628-A Method for regulating and controlling light emission of lead halogen perovskite quantum dots 中国科学院理化技术研究所 2024-06-14 CN disclosed
US-11965109-B2 Semiconductor film composition, method for manufacturing semiconductor film composition, method for manufacturing semiconductor member, method for manufacturing semiconductor processing material, and semiconductor device MITSUI CHEMICALS, INC. (JP) 2024-04-23 US disclosed
US-20240027927-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJIFILM BUSINESS INNOVATION CORP. (JP) 2024-01-25 US disclosed
EP-4310593-A1 ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS FUJIFILM Business Innovation Corp. (JP) 2024-01-24 EP disclosed
US-20050233253-A1 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether WAKO PURE CHEMICAL INDUSTRIES, LTD (JP) 2005-10-20 US disclosed
US-20050145411-A1 Material for the production of functional elements comprising at least one foamable area and use of said functional elements for positioning and mounting objects JENOPTIK AUTOMATISIERUNGSTECHNIK GMBH (DE) 2005-07-07 US disclosed
US-20050020710-A1 Hybrid onium salt WAKO PURE CHEMICALS INDUSTRIES, LTD. (JP) 2005-01-27 US disclosed
EP-1481973-A1 HETEROCYCLE-BEARING ONIUM SALTS Wako Pure Chemical Industries, Ltd. (JP) 2004-12-01 EP disclosed
EP-1443042-A1 HYBRID ONIUM SALT Wako Pure Chemical Industries, Ltd. (JP) 2004-08-04 EP disclosed
EP-0529002-B1 FLUORESCENT PORPHYRIN, AND FLUORESCENT PHTHALOCYANINE - POLYETHYLENE GLYCOL, POLYOL, AND SACCHARIDE DERIVATIVES AS FLUORESCENT PROBES HYPERION INC (US) 2001-10-04 EP disclosed
CN-1293680-A Method for producing aqueous polymer dispersions containing colorants BASF AG (DE) 2001-05-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050233253-A1 Diphenylsulfonium compounds in which the S atom is additionally attached to a xanthene-9-onyl-2-yl- or coumarin-7-yl- ring; acid generator for a chemically amplified resist; photopolymerization initiator for polymerizing an epoxide or a vinyl ether NOX4, CBR1, CBR3 HPGD 1227/4885CYP1A2 276/4885ALDH1A1 1190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.